Nephroprotective effect of SGLT2 inhibitors in elderly patients with type 2 diabetes mellitus and hypertension: a real-world population-based cohort study
SGLT2i significantly reduced the risk of rapid eGFR decline in elderly patients with T2DM and hypertension, but the synergistic effect with RASi remains unclear.
Authors
- Shasha Geng (ORCID: https://orcid.org/0000-0002-7443-1618)
- Xin Chen (ORCID: https://orcid.org/0000-0003-0939-0538)
- Yingqian Zhu (ORCID: https://orcid.org/0000-0001-7452-1536)
- Hua Jiang (ORCID: https://orcid.org/0009-0000-1807-3775)
- Huixiao Yuan
- Qingqing Li (ORCID: https://orcid.org/0000-0002-1154-3719)
- Yang Li (ORCID: https://orcid.org/0000-0002-0088-1544)
- Xiaoli Wang (ORCID: https://orcid.org/0000-0003-2774-300X)
- Xiaotong Guo
- Yue Liu (ORCID: https://orcid.org/0000-0002-6025-5326)
- Jianli Ge (ORCID: https://orcid.org/0000-0002-4099-5474)
Institutions
- Shanghai East Hospital (CN)
- Shanghai Pudong Institute of Education Development (CN)
Publication Details
- Journal
- Postgraduate Medicine
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1080/00325481.2024.2426442
- Citations
- 6
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.15
Funders
- National Key Research and Development Program of China